Grail, Inc. (NASDAQ:GRAL) Short Interest Update

Grail, Inc. (NASDAQ:GRAL) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 5,810,000 shares, an increase of 18.6% from the December 31st total of 4,900,000 shares. Based on an average trading volume of 773,500 shares, the days-to-cover ratio is presently 7.5 days. Approximately 20.2% of the shares of the company are sold short.

Insider Activity at Grail

In other news, CFO Aaron Freidin sold 30,452 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Institutional Investors Weigh In On Grail

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FNY Investment Advisers LLC purchased a new stake in Grail in the fourth quarter valued at approximately $26,000. New York State Common Retirement Fund purchased a new stake in shares of Grail in the 4th quarter valued at about $59,000. Wilmington Savings Fund Society FSB purchased a new position in Grail during the 4th quarter worth $64,000. Manchester Capital Management LLC purchased a new position in Grail during the 4th quarter worth $123,000. Finally, China Universal Asset Management Co. Ltd. acquired a new stake in shares of Grail in the 4th quarter valued at approximately $127,000.

Grail Trading Down 3.9 %

NASDAQ GRAL traded down $1.23 on Friday, reaching $30.28. 1,748,183 shares of the company’s stock traded hands, compared to its average volume of 935,055. The stock has a 50 day moving average price of $20.34 and a 200-day moving average price of $16.66. Grail has a fifty-two week low of $12.33 and a fifty-two week high of $32.65.

Grail (NASDAQ:GRAL) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The firm had revenue of $28.65 million for the quarter. Research analysts forecast that Grail will post -65.16 earnings per share for the current year.

Wall Street Analyst Weigh In

GRAL has been the topic of several research analyst reports. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They issued a “peer perform” rating on the stock. Guggenheim started coverage on shares of Grail in a report on Thursday, October 17th. They issued a “neutral” rating for the company. Finally, Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.